proxyvotesnow.com

Home › Companies › TANDEM DIABETES CARE INC. › 2023-2024

TANDEM DIABETES CARE INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and TANDEM DIABETES CARE INC.’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 13Ballot items
  • 340Asset managers
  • 3,780Fund votes
  • 2024-05-22Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TANDEM DIABETES CARE INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by TANDEM DIABETES CARE INC.

These tallies are TANDEM DIABETES CARE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TANDEM DIABETES CARE INC. — official shareholder meeting results, meeting held 2024-05-22
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Rebecca Robertson 47,954,7952,561,51532,594 --4,013,638 Majority: yes
Elect Director: Dick Allen 45,909,7964,617,30921,799 --4,013,638 Majority: yes
Elect Director: Myoungil Cha 49,683,636842,35522,913 --4,013,638 Majority: yes
Elect Director: Peyton Howell 49,481,6301,045,77821,496 --4,013,638 Majority: yes
Elect Director: Joao Malagueira 50,040,471484,79023,643 --4,013,638 Majority: yes
Elect Director: Kathleen McGroddy-Goetz 48,668,9281,846,37933,597 --4,013,638 Majority: yes
Elect Director: John Sheridan 50,341,404186,61620,884 --4,013,638 Majority: yes
Elect Director: Rajwant Sodhi 48,933,3451,594,61120,948 --4,013,638 Majority: yes
Elect Director: Christopher Twomey 45,464,7645,049,10935,031 --4,013,638 Majority: yes
Proposal 2: To approve the Company's 2013 Employee Stock Purchase Plan, as amended, to increase the number of shares authorized for issuance under the plan by 3,000,000 shares 50,419,028117,50112,375 --4,013,638 Majority: yes
Proposal 3: To approve the Company's 2023 Long-Term Incentive Plan, as amended, to increase the number of shares authorized for issuance under the plan by 3,000,000 shares 47,565,5782,958,51624,810 --4,013,638 Majority: yes
Proposal 4: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement 47,949,0632,300,733299,108 --4,013,638 Majority: yes
Proposal 5: To ratify of the appointment of Ernst & Young LLP to serve as the Company's independent registered public accountant for the year ending December 31, 2024 53,170,6691,369,00022,873 ---- Majority: yes

Source: TANDEM DIABETES CARE INC., Form 8-K — read the filing on EDGAR.

How asset managers voted at the TANDEM DIABETES CARE INC. 2023-2024 meeting

Each item below shows how the 340 asset managers that disclosed a TANDEM DIABETES CARE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on a non-binding, advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 18 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 47,949,063AGAINST: 2,300,733

TANDEM DIABETES CARE INC.’s own tally for this item (“Proposal 4: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement”): 47,949,063 for, 2,300,733 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 74% for, 4% against (78% of the company cast a for/against vote).

The 339 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 96%
FOR: 96.1%AGAINST: 3.5%ABSTAIN: 0.4%NOT VOTED: 0.0%UNKNOWN: 0.0%
Largest asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Capital Group9,365,0030 00For
Vanguard9,034,7790 00For
BlackRock5,575,936640 00For
ArrowMark Colorado Holdings LLC2,509,7180 00For
Janus Henderson2,150,8910 00For
Fidelity1,968,7780 00For
State Street1,930,0120 00For
MARSHALL WACE, LLP01,455,482 00Against
Park West Asset Management LLC1,447,2530 00For
JANUS INVESTMENT FUND1,368,4230 00For
GW&K Investment Management, LLC1,145,9590 00For
GEODE CAPITAL MANAGEMENT, LLC1,038,2190 00For
JENNISON ASSOCIATES LLC967,0775,681 00For
Charles Schwab801,6640 00For
Stephens Investment Management Group LLC785,0340 00For
WEATHERBIE CAPITAL, LLC722,3980 00For
NEXT CENTURY GROWTH INVESTORS LLC708,6590 00For
JACOBS LEVY EQUITY MANAGEMENT, INC627,8320 00For
Advisors' Inner Circle Fund II620,0000 00For
MERIDIAN FUND INC501,4490 00For
DRIEHAUS CAPITAL MANAGEMENT LLC492,7020 00For
Point72444,6660 00For
ALGER FUNDS427,2560 00For
BROWN CAPITAL MANAGEMENT LLC422,1470 00For
Integral Health Asset Management, LLC421,4910 00For

Showing the 25 largest of 339 asset managers. See all 339 in the interactive database.

2. To approve the Company's 2013 Employee Stock Purchase Plan, as amended, to increase the number of shares authorized for issuance under the plan.

COMPENSATIONMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 50,419,028AGAINST: 117,501

TANDEM DIABETES CARE INC.’s own tally for this item (“Proposal 2: To approve the Company's 2013 Employee Stock Purchase Plan, as amended, to increase the number of shares authorized for issuance under the plan by 3,000,000 shares”): 50,419,028 for, 117,501 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 78% for, 0.2% against (78% of the company cast a for/against vote).

The 89 asset managers below cast 99.9% of the shares they voted on this item FOR (26,899,033 for, 3,992 against).

FOR 99.9%
FOR: 26,899,033 (100.0%)AGAINST: 3,992 (0.0%)
Largest asset managers voting on “To approve the Company's 2013 Employee Stock Purchase Plan, as amended, to increase the number of shares autho” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,435,6490 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,21912 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS427,2560 00For
First Light Asset Management, LLC394,4690 00For
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II86,8670 00For
Invesco81,5780 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

3. To approve the Company's 2023 Long-Term Incentive Plan, as amended, to increase the number of shares authorized for issuance under the plan.

COMPENSATIONMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 47,565,578AGAINST: 2,958,516

TANDEM DIABETES CARE INC.’s own tally for this item (“Proposal 3: To approve the Company's 2023 Long-Term Incentive Plan, as amended, to increase the number of shares authorized for issuance under the plan by 3,000,000 shares”): 47,565,578 for, 2,958,516 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 74% for, 5% against (78% of the company cast a for/against vote).

The 89 asset managers below cast 98% of the shares they voted on this item FOR (26,320,206 for, 530,614 against).

FOR 98%
FOR: 26,320,206 (98.0%)AGAINST: 530,614 (2.0%)ABSTAIN: 3,980 (0.0%)UNKNOWN: 10 (0.0%)
Largest asset managers voting on “To approve the Company's 2023 Long-Term Incentive Plan, as amended, to increase the number of shares authorize” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity995,671439,978 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,18447 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS427,2560 00For
First Light Asset Management, LLC394,4690 00For
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II86,8670 00For
Invesco81,5780 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

4. To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Christopher Twomey

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%
FOR: 45,464,764AGAINST: 5,049,109

TANDEM DIABETES CARE INC.’s own tally for this item (“Elect Director: Christopher Twomey”): 45,464,764 for, 5,049,109 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 70% for, 8% against (78% of the company cast a for/against vote).

The 87 asset managers below cast 91% of the shares they voted on this item FOR (24,151,930 for, 2,348,426 against).

FOR 91%9%
FOR: 24,151,930 (91.1%)AGAINST: 2,348,426 (8.9%)ABSTAIN: 3,980 (0.0%)
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Christopher T” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard7,383,1361,558,469 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,417,69517,954 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,16170 00For
MERIDIAN FUND INC0501,449 00Against
ALGER FUNDS427,2560 00For
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments092,421 00Against
ALGER FUNDS II86,8670 00For
Invesco81,5780 00For
SEI076,884 00Against

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

5. To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Dick Allen

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 45,909,796AGAINST: 4,617,309

TANDEM DIABETES CARE INC.’s own tally for this item (“Elect Director: Dick Allen”): 45,909,796 for, 4,617,309 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 71% for, 7% against (78% of the company cast a for/against vote).

The 87 asset managers below cast 98% of the shares they voted on this item FOR (25,871,956 for, 628,400 against).

FOR 98%
FOR: 25,871,956 (97.6%)AGAINST: 628,400 (2.4%)ABSTAIN: 3,980 (0.0%)
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Dick Allen” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,435,6490 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,076155 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS0427,256 00Against
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II086,867 00Against
Invesco81,5780 00For
SEI76,8840 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

6. To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Joao Malagueira

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 50,040,471AGAINST: 484,790

TANDEM DIABETES CARE INC.’s own tally for this item (“Elect Director: Joao Malagueira”): 50,040,471 for, 484,790 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 78% for, 0.8% against (78% of the company cast a for/against vote).

The 87 asset managers below cast 99.9% of the shares they voted on this item FOR (26,500,286 for, 70 against).

FOR 99.9%
FOR: 26,500,286 (100.0%)AGAINST: 70 (0.0%)ABSTAIN: 3,980 (0.0%)
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Joao Malaguei” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,435,6490 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,16170 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS427,2560 00For
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II86,8670 00For
Invesco81,5780 00For
SEI76,8840 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

7. To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: John Sheridan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 50,341,404AGAINST: 186,616

TANDEM DIABETES CARE INC.’s own tally for this item (“Elect Director: John Sheridan”): 50,341,404 for, 186,616 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 78% for, 0.3% against (78% of the company cast a for/against vote).

The 87 asset managers below cast 99.9% of the shares they voted on this item FOR (26,500,286 for, 70 against).

FOR 99.9%
FOR: 26,500,286 (100.0%)AGAINST: 70 (0.0%)ABSTAIN: 3,980 (0.0%)
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: John Sheridan” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,435,6490 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,16170 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS427,2560 00For
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II86,8670 00For
Invesco81,5780 00For
SEI76,8840 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

8. To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Kathleen McGroddy-Goetz

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 48,668,928AGAINST: 1,846,379

TANDEM DIABETES CARE INC.’s own tally for this item (“Elect Director: Kathleen McGroddy-Goetz”): 48,668,928 for, 1,846,379 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 75% for, 3% against (78% of the company cast a for/against vote).

The 87 asset managers below cast 98% of the shares they voted on this item FOR (25,872,881 for, 627,475 against).

FOR 98%
FOR: 25,872,881 (97.6%)AGAINST: 627,475 (2.4%)ABSTAIN: 3,980 (0.0%)
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Kathleen McGr” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,435,6490 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,123108 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS0427,256 00Against
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II086,867 00Against
Invesco81,5780 00For
SEI76,8840 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

9. To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Myoungil Cha

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 49,683,636AGAINST: 842,355

TANDEM DIABETES CARE INC.’s own tally for this item (“Elect Director: Myoungil Cha”): 49,683,636 for, 842,355 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 77% for, 1% against (78% of the company cast a for/against vote).

The 87 asset managers below cast 99.9% of the shares they voted on this item FOR (26,500,063 for, 293 against).

FOR 99.9%
FOR: 26,500,063 (100.0%)AGAINST: 293 (0.0%)ABSTAIN: 3,980 (0.0%)
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Myoungil Cha” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,435,6490 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,16170 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS427,2560 00For
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II86,8670 00For
Invesco81,5780 00For
SEI76,8840 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

10. To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Peyton Howell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 49,481,630AGAINST: 1,045,778

TANDEM DIABETES CARE INC.’s own tally for this item (“Elect Director: Peyton Howell”): 49,481,630 for, 1,045,778 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 77% for, 2% against (78% of the company cast a for/against vote).

The 87 asset managers below cast 99.9% of the shares they voted on this item FOR (26,500,063 for, 293 against).

FOR 99.9%
FOR: 26,500,063 (100.0%)AGAINST: 293 (0.0%)ABSTAIN: 3,980 (0.0%)
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Peyton Howell” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,435,6490 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,16170 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS427,2560 00For
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II86,8670 00For
Invesco81,5780 00For
SEI76,8840 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

11. To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Rajwant Sodhi

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 48,933,345AGAINST: 1,594,611

TANDEM DIABETES CARE INC.’s own tally for this item (“Elect Director: Rajwant Sodhi”): 48,933,345 for, 1,594,611 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 76% for, 2% against (78% of the company cast a for/against vote).

The 87 asset managers below cast 98% of the shares they voted on this item FOR (25,944,350 for, 556,006 against).

FOR 98%
FOR: 25,944,350 (97.9%)AGAINST: 556,006 (2.1%)ABSTAIN: 3,980 (0.0%)
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Rajwant Sodhi” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,435,6490 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,123108 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS0427,256 00Against
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II086,867 00Against
Invesco81,5780 00For
SEI76,8840 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

12. To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Rebecca Robertson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 47,954,795AGAINST: 2,561,515

TANDEM DIABETES CARE INC.’s own tally for this item (“Elect Director: Rebecca Robertson”): 47,954,795 for, 2,561,515 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 74% for, 4% against (78% of the company cast a for/against vote).

The 87 asset managers below cast 99.7% of the shares they voted on this item FOR (26,428,594 for, 71,762 against).

FOR 99.7%
FOR: 26,428,594 (99.7%)AGAINST: 71,762 (0.3%)ABSTAIN: 3,980 (0.0%)
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2025 annual meeting of stockholders: Rebecca Rober” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,435,6490 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,16170 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS427,2560 00For
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II86,8670 00For
Invesco81,5780 00For
SEI76,8840 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

13. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 53,170,669AGAINST: 1,369,000

TANDEM DIABETES CARE INC.’s own tally for this item (“Proposal 5: To ratify of the appointment of Ernst & Young LLP to serve as the Company's independent registered public accountant for the year ending December 31, 2024”): 53,170,669 for, 1,369,000 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 64,563,000 outstanding shares: 82% for, 2% against (84% of the company cast a for/against vote).

The 87 asset managers below cast 99.8% of the shares they voted on this item FOR (26,473,020 for, 31,286 against).

FOR 99.8%
FOR: 26,473,020 (99.9%)AGAINST: 31,286 (0.1%)ABSTAIN: 3,980 (0.0%)
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fi” at TANDEM DIABETES CARE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,941,6050 00For
Capital Group4,682,4950 00For
BlackRock3,966,1660 00For
Fidelity1,435,6490 00For
JANUS INVESTMENT FUND1,368,4230 00For
Advisors' Inner Circle Fund II620,0000 00For
State Street544,18447 00For
MERIDIAN FUND INC501,4490 00For
ALGER FUNDS427,2560 00For
Charles Schwab382,7230 00For
OLD WESTBURY FUNDS INC355,0000 00For
First Trust339,7740 00For
Nationwide291,2410 00For
Brown Capital Management Mutual Funds257,8320 00For
AMG FUNDS214,4030 00For
Columbia Threadneedle179,0960 00For
Jackson National144,6120 00For
DRIEHAUS MUTUAL FUNDS141,1530 00For
TIAA139,3200 00For
AMERICAN BEACON FUNDS125,8440 00For
Bridge Builder Trust117,9380 00For
Russell Investments92,4210 00For
ALGER FUNDS II86,8670 00For
Invesco81,5780 00For
SEI76,8840 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

Largest TANDEM DIABETES CARE INC. shareholders voting in 2023-2024

Ranked by the number of TANDEM DIABETES CARE INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 64,563,000 shares outstanding at the time of that meeting.

Top TANDEM DIABETES CARE INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Capital Group 14.51%
2Vanguard 13.99%
3BlackRock 8.64%
4ArrowMark Colorado Holdings LLC 3.89%
5Janus Henderson 3.33%
6Fidelity 3.05%
7State Street 2.99%
8MARSHALL WACE, LLP 2.25%
9Park West Asset Management LLC 2.24%
10JANUS INVESTMENT FUND 2.12%

Reported TANDEM DIABETES CARE INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

TANDEM DIABETES CARE INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 18.74% 13F
Vanguard Group 10.94% 13F
Capital World Investors 10.12% DEF14A
Eminence Capital, LP 8.01% DEF14A
State Street 3.47% 13F
Goldman Sachs 2.22% 13F
Millennium Management 1.63% 13F
Two Sigma 1.58% 13F
Capital International 1.58% 13F
FMR (Fidelity) 1.35% 13F

Percentages above are of 64,563,000 shares outstanding, as reported by TANDEM DIABETES CARE INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TANDEM DIABETES CARE INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At TANDEM DIABETES CARE INC.'s shareholder meeting held 2024-05-22, in the 2023-2024 proxy season, 340 asset managers reported how they voted on 13 ballot items in their SEC Form N-PX filings, covering 3,780 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of our named executive officers. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TANDEM DIABETES CARE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

TANDEM DIABETES CARE INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.